drugset / Trial / NCT00004195
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
Phase 2
Completed
28 enrolled
University of Alabama at Birmingham
Glaxo Wellcome · collabNational Cancer Institute (NCI) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
RATIONALE: Eniluracil may increase the effectiveness of chemotherapy by blocking tumor enzymes that break down chemotherapy drugs. PURPOSE: Randomized phase II trial to determine the effectiveness of eniluracil followed by surgery in treating patients who have primary or metastatic colorectal cancer.
Timeline
- Start
- 1998-09
- Primary completion
- 1999-10
- Completion
- 2001-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | eniluracil | Unknown | 20 mg | Oral |